Top Qs
Timeline
Chat
Perspective

Crisugabalin

Drug for chronic pain From Wikipedia, the free encyclopedia

Crisugabalin
Remove ads

Crisugabalin (HSK16149) is a selective GABA analog in development for the treatment of chronic pain. It has a wider therapeutic index than pregabalin, which has a similar mechanism of action. In China, it was approved in May 2024 for the treatment of diabetic peripheral neuropathic pain[1] and approved in July 2024 for the treatment of postherpetic neuralgia.[2] In the United States, it is in Phase III trials as of 2023.[3][4] The drug can be administered with or without food.[5]

Quick Facts Legal status, Identifiers ...
Remove ads

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads